94 related articles for article (PubMed ID: 20306252)
1. Murine models of human acute myeloid leukemia.
Fortier JM; Graubert TA
Cancer Treat Res; 2010; 145():183-96. PubMed ID: 20306252
[TBL] [Abstract][Full Text] [Related]
2. Diversity of human leukemia xenograft mouse models: implications for disease biology.
Meyer LH; Debatin KM
Cancer Res; 2011 Dec; 71(23):7141-4. PubMed ID: 22088964
[TBL] [Abstract][Full Text] [Related]
3. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers.
Henschler R; Göttig S; Junghahn I; Bug G; Seifried E; Müller AM; Fichtner I
Leuk Res; 2005 Oct; 29(10):1191-9. PubMed ID: 15941586
[TBL] [Abstract][Full Text] [Related]
5. Searching for leukemia stem cells--not yet the end of the road?
Jordan CT
Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
[TBL] [Abstract][Full Text] [Related]
6. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
8. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
9. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
10. Review: genetic models of acute myeloid leukaemia.
McCormack E; Bruserud O; Gjertsen BT
Oncogene; 2008 Jun; 27(27):3765-79. PubMed ID: 18264136
[TBL] [Abstract][Full Text] [Related]
11. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
12. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
13. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.
Yamashita N; Osato M; Huang L; Yanagida M; Kogan SC; Iwasaki M; Nakamura T; Shigesada K; Asou N; Ito Y
Br J Haematol; 2005 Nov; 131(4):495-507. PubMed ID: 16281942
[TBL] [Abstract][Full Text] [Related]
15. In vivo optical imaging of acute myeloid leukemia by green fluorescent protein: time-domain autofluorescence decoupling, fluorophore quantification, and localization.
McCormack E; Micklem DR; Pindard LE; Silden E; Gallant P; Belenkov A; Lorens JB; Gjertsen BT
Mol Imaging; 2007; 6(3):193-204. PubMed ID: 17532885
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone.
Yonou H; Yokose T; Kamijo T; Kanomata N; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2001 Mar; 61(5):2177-82. PubMed ID: 11280783
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
18. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
19. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
20. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
